The group provides consultancy and training across a wide range of specialisms within the pharmaceutical, biotech, and medical device sectors. In addition, the group offers engineering and CQV services for sterilisation, depyrogenation, thermal system monitoring, hydrogen peroxide systems, and steam quality testing.
The group has developed an exceptional reputation for excellent on-site consultancy work with procedures and systems, which has enabled it to become an approved supplier for many of its clients.
The group is now being offered for sale as part of the shareholder’s eventual retirement plans.
Key Highlights
- Serves a number of prestigious and blue-chip organisations.
- The most lucrative and consistent work of the group’s is linked to clients that are starting out and moving from R&D or clinical trials to commercial manufacturing.
- Operates within the strong biotech start up market in the UK and continued investments due to tax breaks for high tech pharma organisations in the Republic of Ireland will provide ongoing work for the group.
- Continuing to expand the team and creating a more structured management staff approach will provide a strong platform for further development.
- Directors willing to remain with the group long-term to assist with continued growth, depending on buyer preference.
- Operates from easily relocatable leasehold premises.
Financial Highlights
- Turnover of £2.2m achieved in YE24 with an adjusted EBITDA of £720k.
- Projected turnover of £2.8m with an adjusted EBITDA of £933k in YE25.
- Continuous, recurring revenue streams account for approximately 50% of turnover.
